Skip to content

Investigating virtual immersive experiences in the management of chronic pain – the VIPA study

Investigating Virtual Immersive experiences in the management of chronic widespread PAin – the VIPA study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN46681140
Enrollment
30
Registered
2021-02-22
Start date
2020-10-01
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia syndrome, chronic widespread pain Musculoskeletal Diseases Fibromyalgia syndrome, chronic widespread pain

Interventions

Currently, there are few studies investigating the use of virtual reality (VR) in a chronic pain setting. The studies that have been published include participants with a range of different chronic pa

Sponsors

University of East Anglia
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged =18 years 2. Ability to communicate using conversational English and has the capacity to consent 3. Confirmed diagnosis of Fibromyalgia Syndrome (FMS) or chronic pain following a total knee replacement 4. Current chronic widespread pain for =3 months preceding recruitment

Exclusion criteria

Exclusion criteria: 1. Any co-morbid condition that is exacerbated by exposure to flashing lights or screens 2. Diagnosis of cognitive impairment 3. Current visual or hearing impairment that would prevent the participant from using the technology included in the experiments

Design outcomes

Primary

MeasureTime frame
Acceptability measured using post-intervention subjective experience questionnaires including the simulator sickness questionnaire post-intervention within each experiment

Secondary

MeasureTime frame
1. Pain measured using the visual analogue score (VAS) and McGill Pain Questionnaire Short Form (MPQ-SF) at baseline and post-intervention within each experiment 2. Electroencephalogram (EEG) characteristics measured using EEG immediately pre-intervention (2 minutes resting-state eyes closed, 2 minutes resting-state eyes open), during the VR activity, after each VR activity (2 minutes resting state), and immediately post-intervention (2 minutes resting-state eyes closed, 2 minutes resting-state eyes open) within experiments 2, 3 and 4

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026